Press Releases

See our recent news and announcements below. If you have any questions or for media inquiries, please contact for assistance or see specified media contact details within each release.

Pyramid Biosciences Expands Precision Oncology Pipeline

Waltham, MA, November 16, 2021 –

Pyramid Biosciences, Inc., a clinical-stage biotechnology company developing a portfolio of precision therapies targeting a wide range of diseases, today announced the global licensing of the novel monopolar spindle1 (MPS1) called VRN-08 and a second undisclosed asset from Voronoi Inc., a South Korea- based biotechnology company the develops novel kinase inhibitors and target protein degraders. The milestone-based deal is worth up to $846 million dollars (USD). [click to read more]